Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.
Malbrán A, Riedl M, Ritchie B, Smith WB, Yang W, Banerji A, Hébert J, Gleich GJ, Hurewitz D, Jacobson KW, Bernstein JA, Khan DA, Kirkpatrick CH, Resnick D, Li H, Fernández Romero DS, Lumry W.
Malbrán A, et al.
Clin Exp Immunol. 2014 Aug;177(2):544-53. doi: 10.1111/cei.12358.
Clin Exp Immunol. 2014.
PMID: 24749847
Free PMC article.
Clinical Trial.